Efficacy and safety of single-inhaler extrafine triple therapy versus inhaled corticosteroid plus long-acting beta2 agonist in eastern Asian patients with COPD: the TRIVERSYTI randomised controlled trial
Sign Up to like & getrecommendations! Published in 2021 at "Respiratory Research"
DOI: 10.1186/s12931-021-01683-2
Abstract: Background A single-inhaler extrafine triple combination of beclometasone dipropionate (BDP), formoterol fumarate (FF) and glycopyrronium (G) has been developed for maintenance therapy of chronic obstructive pulmonary disease (COPD). This study evaluated the efficacy and safety… read more here.
Keywords: patients copd; inhaler; single inhaler; bdp ... See more keywords
Residual Dyspnea May Predict Small Airways Dysfunction and Poor Responsiveness to Single-Inhaler Triple Therapy in Asthmatic Patients
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Asthma and Allergy"
DOI: 10.2147/jaa.s381953
Abstract: Purpose Recently, single-inhaler triple therapy (SITT) has demonstrated efficacy in patients with uncontrolled asthma who were symptomatic despite treatment with inhaled corticosteroids/long-acting β2 agonists. However, the characteristics of patients who benefit from SITT remain unclear… read more here.
Keywords: inhaler triple; dyspnea; single inhaler; triple therapy ... See more keywords
When single-inhaler triple therapy is a preferred option in asthma management?
Sign Up to like & getrecommendations! Published in 2022 at "Annals of Thoracic Medicine"
DOI: 10.4103/atm.atm_341_22
Abstract: Asthma control is the main goal of management. Unfortunately, most asthma patients with moderate–severe asthma remain uncontrolled despite receiving standard treatment of inhaled corticosteroids (ICS) with long-acting β2 agonists (LABA). The addition of long-acting antimuscarinic… read more here.
Keywords: inhaler triple; single inhaler; option; triple therapy ... See more keywords
Therapeutic Response to Single-Inhaler Triple Therapies in Moderate-to-Severe COPD
Sign Up to like & getrecommendations! Published in 2023 at "Respiratory Care"
DOI: 10.4187/respcare.10188
Abstract: BACKGROUND: COPD is characterized by progressive and irreversible air flow limitations. Single-inhaler therapies (SITTs) incorporating an inhaled corticosteroid, a long-acting muscarinic antagonist, and a long-acting β2-agonist have been shown to effectively alleviate symptoms and improve… read more here.
Keywords: inhaler; single inhaler; copd; effect ... See more keywords